Navigation Links
JCI table of contents: June 20, 2008
Date:6/20/2008

EDITOR'S PICK: Smoking out the mediators of airway damage caused by pollutants

New insight into how pollution and cigarette smoke damage airways has been provided by Pierangelo Geppetti and colleagues, at the University of Florence, Italy, who studied the effects of such chemicals on guinea pig airways. As discussed, in an accompanying commentary, by Sidney Simon and Wolfgang Liedtke, at Duke University Medical Center, it is hoped that this information will help in the development of therapeutics to combat the effects of pollutants and perhaps help individuals with smoke-related diseases such as chronic obstructive pulmonary disease and chronic asthma.

In the study, chemicals found in cigarette smoke were shown to activate signaling in nerves that ended in the airways of guinea pigs. These effects were abolished using a molecule that inhibited a protein known as TRPA1. Consistent with a central role for TRPA1 in sensing chemicals in cigarette smoke, no signaling in nerves that end in the airways was observed in mice lacking TRPA1 after exposure to the chemicals in cigarette smoke. Further analysis showed that alpha,beta-unsaturated aldehydes were the chemicals that activated TRPA1, suggesting that they might contribute to the airway damage that occurs in smoke-related diseases.

TITLE: Cigarette smokeinduced neurogenic inflammation is mediated by alpha,beta-unsaturated aldehydes and the TRPA1 receptor in rodents

AUTHOR CONTACT:
Pierangelo Geppetti
University of Florence, Florence, Italy.
Phone: 39-055-427-1329; Fax: 39-055-427-1280; E-mail: pierangelo.geppetti@unifi.it.

View the PDF of this article at: https://www.the-jci.org/article.php?id=34886

ACCOMPANYING COMMENTARY

TITLE: How irritating: the role of TRPA1 in sensing cigarette smoke and aerogenic oxidants in the airwa
'/>"/>

Contact: Karen Honey
press_releases@the-jci.org
215-573-1850
Journal of Clinical Investigation
Source:Eurekalert

Page: 1 2 3 4 5 6 7 8 9

Related medicine news :

1. Ranbaxy Receives Tentative Approval to Manufacture and Market Galantamine Tablets on an Exclusive Basis
2. Schering-Plough/Merck Pharmaceuticals Announce FDA Filing Acceptance of New Drug Application for Loratadine/Montelukast Tablet
3. JCI table of contents: Sept. 4, 2007
4. FDA Seeks to Regulate Complementary and Alternative Medicine; Products Such as Vegetable Juice Could Be Restricted for Medical Use
5. Actavis Launches Carvedilol Tablets in the U.S.
6. Mylan Announces Final FDA Approval for Carvedilol Tablets
7. Ranbaxy Gains Approval to Manufacture and Market Carvedilol Tablets in the U.S. Market
8. Actavis Launches Amlodipine Tablets in the U.S.
9. Implantable device designed to detect, stop seizures under study at MCG
10. Stevens Health, Technology and Society roundtable: Sept. 19
11. Fruity vegetables and fish reduce asthma and allergies

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/4/2009)...wswire-FirstCall/ -- Hill-Rom Holdings, Inc. (NYSE...arter dividend of $0.1025 per share. This dividend...December 3, 2009, and is payable on December 31, 2...2009. ,, ABOUT HILL-ROM HOLDINGS, INC. ,...and provider of medical technologies and related s...
(Date:12/4/2009)...swire-FirstCall/ -- MedClean Technologies, Inc. (O...ny has entered into a preferred stock purchase agr...limited liability company, doing business as Soci...he Purchase Agreement, MedClean will receive up to...d to sell up to 750 shares of its Series C Preferr...
(Date:12/4/2009)... Reform Bills Will Increase Deficit ,, WASHINGT...ms that the pending health reform bills aren,t rea...savings take effect, Congress has allowed the vast...past two decades to take effect and produce signif...et and Policy Priorities shows. ,, The analysis...
(Date:12/4/2009).../ -- The National Cancer Institute has awarded a $...inson Cancer Research Center to become the nation,...Contact Center. ,, The move will create 60 new ...e size of its current CIS workforce - once the con...heduled for March 15, 2010. The Seattle CIS center...
(Date:12/4/2009)...progress has been made over the last 15 years in t...treat epilepsy and its complications. Yet this pr... of the 50 million people around the world, includ... United States who have the disorder, , Accordin...merican Epilepsy Society (AES), there is an enormo...
Breaking Medicine News(10 mins):Health News:MedClean Technologies Enters Into Preferred Stock Agreement of Up to $7.5 Million 2Health News:MedClean Technologies Enters Into Preferred Stock Agreement of Up to $7.5 Million 3Health News:Congress Has Allowed Most Previous Medicare Cuts to Take Effect, New Study Shows 2Health News:Congress Has Allowed Most Previous Medicare Cuts to Take Effect, New Study Shows 3Health News:Congress Has Allowed Most Previous Medicare Cuts to Take Effect, New Study Shows 4Health News:Hutchinson Center Wins $55.4 Million Contract to Become Sole Operator of the NCI Cancer Information Service 2Health News:Epilepsy patients caught in treatment gap are not getting state-of-the-art care 2Health News:Epilepsy patients caught in treatment gap are not getting state-of-the-art care 3Health News:Epilepsy patients caught in treatment gap are not getting state-of-the-art care 4
...s from the University of Pittsburgh School of Medi...h for an effective treatment for human liver canc...ics. Using a newly available monoclonal antib... According to the researchers, this finding has...
...es, if properly managed, could serve as important ...ty of Missouri-Columbia researcher has revealed . ...n the United States, and approximately 70 percent ...bitat for species native to the area. Golf courses...
...ricas biggest eye care companies has had its recen... approved by the Food and Drug Administration . ...n is the first Lasik device to correct one of a pa... all the nearsightedness to help distance vision ...
...which binds estrogen receptor alpha (ER-alpha), is...ver, one-third of new breast cancers lack detectab...are more aggressive and have a worse prognosis tha...ublication in the August print issue of the Journa...
...ransplant Week this year, in UK, is being taken ve...ecently aims to make aware the desperate need of o... the UK. The campaign has been launched to rai... In the UK every year, more than 600 patients...
...blished in the New England Journal of Medicine has... with folic acid . The extensive study whic...m Laval University in Quebec found that the rate o...086 percent afterward. The scientists were r...
Other Medicine News:Health News:A New Monoclonal Antibody Kills Cancer Cells 2Health News:Golf Courses Could Serve as Wildlife Sanctuaries If Managed Properly 2Health News:Food Fortification With Folic Acid Does The Trick 2
(Date:12/4/2009)... TARRYTOWN, N.Y., Dec. 4 Bayer Dia...inners of Bayer,s "Express Your Simple Win Creativ...elected the winning video entries submitted by chi...rand prize is an in-person meeting today with Nick...ke Nick, are: Caleb, age 6, from Danbury, CT, who ...
(Date:12/4/2009)...LMINGTON, Del., Dec. 4 A... US Food and Drug Administration (FDA) has approve...e) Extended Release Tablets as adjunctive (add-on)... Depressive Disorder (MDD). SEROQUEL XR is the onl...reat both major depressive disorder as adjunctive ...
(Date:12/3/2009)...CTON, Mass., Dec. 3 Alle...gs, Inc. (NYSE: HRC ), today announced the launc...ment Manufacturer) business website www.AllenAma...n Amatech(TM) brand identity and includes an onlin...d descriptions and design specifications for the p...
Breaking Medicine Technology:Bayer 'Express Your Simple Win Creativity Contest' Grand Prize Winners Announced 2Bayer 'Express Your Simple Win Creativity Contest' Grand Prize Winners Announced 3US FDA Approves SEROQUEL XR(R) For Add-On Treatment of Major Depressive Disorder 2US FDA Approves SEROQUEL XR(R) For Add-On Treatment of Major Depressive Disorder 3US FDA Approves SEROQUEL XR(R) For Add-On Treatment of Major Depressive Disorder 4US FDA Approves SEROQUEL XR(R) For Add-On Treatment of Major Depressive Disorder 5US FDA Approves SEROQUEL XR(R) For Add-On Treatment of Major Depressive Disorder 6US FDA Approves SEROQUEL XR(R) For Add-On Treatment of Major Depressive Disorder 7US FDA Approves SEROQUEL XR(R) For Add-On Treatment of Major Depressive Disorder 8US FDA Approves SEROQUEL XR(R) For Add-On Treatment of Major Depressive Disorder 9Allen Medical Systems Announces the Launch of New Allen Amatech(TM) OEM Website 2Sinovac Reports Unaudited Second Quarter 2009 Financial Results 54820 1Sinovac Reports Unaudited Second Quarter 2009 Financial Results 54820 2Sinovac Reports Unaudited Second Quarter 2009 Financial Results 54820 3Sinovac Reports Unaudited Second Quarter 2009 Financial Results 54820 4Sinovac Reports Unaudited Second Quarter 2009 Financial Results 54820 5Sinovac Reports Unaudited Second Quarter 2009 Financial Results 54820 6Sinovac Reports Unaudited Second Quarter 2009 Financial Results 54820 7Sinovac Reports Unaudited Second Quarter 2009 Financial Results 54820 8Sinovac Reports Unaudited Second Quarter 2009 Financial Results 54820 9Sinovac Reports Unaudited Second Quarter 2009 Financial Results 54820 10Sinovac Reports Unaudited Second Quarter 2009 Financial Results 54820 11Sinovac Reports Unaudited Second Quarter 2009 Financial Results 54820 12Sinovac Reports Unaudited Second Quarter 2009 Financial Results 54820 13Sinovac Reports Unaudited Second Quarter 2009 Financial Results 54820 14Iterative reconstruction technique significantly reduces patient radiation dose during CT scans 54816 1Nanomagnets guide stem cells to damaged tissue 13621 1
...ers the most comprehensive family of lightweight s...act incision, Glaucoma filtration, and Vitreoretin...eved with minimal tissue trauma and minimal periph... available in 18, 20, and 20-23Ga tapered designs....
...ers the most comprehensive family of lightweight s...act incision, Glaucoma filtration, and Vitreoretin...eved with minimal tissue trauma and minimal periph... available in 18, 20, and 20-23Ga tapered designs....
Lieberman Aspirating Speculum
Lieberman Speculum
Medicine Products: